Drug Pipeline

Mirikizumab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
14
Active Studies
12
Recruiting
5
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-20 NCT07483099
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone)…
Recruitment opened
2026-05-20 NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or…
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-28 NCT07612267 A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving… Phase 4 Not Yet Recruiting
Active Studies by Phase
Phase 4
3
Phase 3
5
Phase 2
4
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06864403 Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch Pouchitis Recruiting
NCT06997965 Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With… Crohn Disease Recruiting
NCT07612267 A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving… Lactation Not Yet Recruiting
Phase 3
NCT05509777 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease Crohn's Disease Recruiting
NCT04844606 A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants… Ulcerative Colitis Recruiting
NCT06937086 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With… Ulcerative Colitis Recruiting
NCT06937099 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to… Crohn's Disease Recruiting
NCT03519945 A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With… Ulcerative Colitis Active, Not Recruiting
Phase 2
NCT06598943 A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely… Ulcerative Colitis Recruiting
NCT07186101 LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to… Ulcerative Colitis Recruiting
NCT07483073 A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or… Colitis, Ulcerative Recruiting
NCT07483099 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone)… Crohn Disease Recruiting
Phase 1
NCT07446101 A Study of Mirikizumab Solution (LY3074828) in Healthy Participants Healthy Recruiting
Not specified
NCT06249555 VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's… Crohn's Disease Recruiting
Sponsors Running Mirikizumab Trials
Disease Areas
Get alerts when Mirikizumab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free